Aducanumab Accelerated Approval Reflects US FDA Flexibility But Raises Doubts About Confirmatory Trial

 
• By Sue Sutter
  
Rabbit in hat
US FDA pulled a rabbit out of a hat with its surprise use of the accelerated approval pathway for aducanumab. • Source: Alamy
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from Approvals

More from Product Reviews